Although we were not able to discriminate the origin of the extracellular biglycan (cancer or stromal cells), we hypothesize that biglycan expression in tumor samples is a direct consequence of the tumorigenic progression, since it was not observed in normal counterparts. This evidence concerns the gene BGN and cancer.